Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart failure
Biotech
Novo Nordisk inks $1B buyout to pump up heart failure plans
The drugmaker has agreed to buy Cardior Pharmaceuticals and its midphase prospect in a deal that could top out above 1 billion euros.
Nick Paul Taylor
Mar 25, 2024 7:20am
Tenaya's cardiac gene therapy boosts long-term survival in mice
Mar 18, 2024 2:33pm
Abbott recalls HeartMate LVAD communication software
Mar 12, 2024 10:25am
BioCardia rejigs phase 3 heart failure data to find a path
Mar 4, 2024 10:15am
Impulse Dynamics nets $136M to bolster heart failure implant
Feb 15, 2024 10:55am
Procyrion raises $57M to complete its percutaneous heart pump
Feb 5, 2024 11:35am